Cargando…
Low concentration of formononetin promotes proliferation of estrogen receptor-positive cells through an ERα-miR-375-PTEN-ERK1/2-bcl-2 pathway
A low dose of formononetin accelerates the proliferation of nasopharyngeal carcinoma cells in vitro; however, the underlying mechanism remains unknown. Here, we investigated the molecular mechanism of formononetin in CNE2 cell proliferation. CNE2 cells were treated with 0 to 1 μM formononetin. To in...
Autores principales: | Guo, Yan-Hong, Tang, Feng-Yan, Wang, Yong, Huang, Wen-Jun, Tian, Jing, Lu, Hui-Ling, Xin, Min, Chen, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725001/ https://www.ncbi.nlm.nih.gov/pubmed/29245959 http://dx.doi.org/10.18632/oncotarget.21923 |
Ejemplares similares
-
ER-α36, a Novel Variant of ER-α, Mediates Estrogen-Stimulated Proliferation of Endometrial Carcinoma Cells via the PKCδ/ERK Pathway
por: Tong, Jing-Shan, et al.
Publicado: (2010) -
Simultaneous Activation of Erk1/2 and Akt Signaling is Critical for Formononetin-Induced Promotion of Endothelial Function
por: Wu, Jinjun, et al.
Publicado: (2021) -
Formononetin promotes angiogenesis through the estrogen receptor alpha-enhanced ROCK pathway
por: Li, Shang, et al.
Publicado: (2015) -
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
por: Mena, Salvador, et al.
Publicado: (2012) -
miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression
por: SHEN, ZHI-YONG, et al.
Publicado: (2014)